Msn Laboratories - Api Division

Msn Laboratories - Api Division company information, Employees & Contact Information

Updated June 2026

Quick answer

Msn Laboratories - Api Division is a Pharmaceutical Manufacturing company. It has approximately 263 employees on record. Contact data was last refreshed in June 2026. Find Msn Laboratories - Api Division's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Established in the Year of 2003, MSN is the leading manufacturer of the Active Pharmaceutical Ingredients with 800+ clients spreading across the Globe. The MSN's API portfolio consist of 400+ APIs which covers the widest range of therapeutic categories. To bolster it's legacy API business, MSN is producing it's active Ingredients across 11 state-of-the-art manufacturing facilities having the total 4000+ work force across all the manufacturing sites . The World Class Integrated research Center housing the 1000+ skilled manpower to deliver the 40+ new APIs every year.

Company Details

Employees
263
Address
Hyderabad, Telangana 500018, In
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
HYDERABAD, Telangana
Looking for a particular Msn Laboratories - Api Division employee's phone or email?

Msn Laboratories - Api Division Questions

News

Novadoz Pharmaceuticals' Corporate Group Entity, MSN Pharmaceuticals Inc., Has Received USFDA Clearance for its State-of-the-Art Manufacturing Facility in Piscataway, NJ - BioSpace

Novadoz Pharmaceuticals' Corporate Group Entity, MSN Pharmaceuticals Inc., Has Received USFDA Clearance for its State-of-the-Art Manufacturing Facility in Piscataway, NJ BioSpace

MSN Laboratories Earns Great Place to Work® Certification: A Celebration of Its People - PR Newswire

MSN Laboratories Earns Great Place to Work® Certification: A Celebration of Its People PR Newswire

MSN Labs eyes acquisitions in CDMO, generics space - Times of India

MSN Labs eyes acquisitions in CDMO, generics space Times of India

MSN Labs launches a new drug for percutaneous coronary intervention - Chennai Patrika

MSN Labs launches a new drug for percutaneous coronary intervention Chennai Patrika

Novadoz Pharmaceuticals Wins Approval for Several New Products in 2022 Including Products Manufactured in its new US based plant - BioSpace

Novadoz Pharmaceuticals Wins Approval for Several New Products in 2022 Including Products Manufactured in its new US based plant BioSpace

Hyderabad-based MSN Labs to begin phase III trial of Molnupiravir - Telangana Today

Hyderabad-based MSN Labs to begin phase III trial of Molnupiravir Telangana Today

Novadoz Pharmaceuticals/MSN Labs is granted FDA Approval of generic Febuxostat Tablets, begins immediate shipping - PR Newswire

Novadoz Pharmaceuticals/MSN Labs is granted FDA Approval of generic Febuxostat Tablets, begins immediate shipping PR Newswire

MSN Labs ties up with Eli Lilly for baricitinib in India - The Economic Times

MSN Labs ties up with Eli Lilly for baricitinib in India The Economic Times

News On Click - Global Prime News

News On Click Global Prime News

MSN Labs enters into License Agreement with DRDO for 2 DG - Chennai Patrika

MSN Labs enters into License Agreement with DRDO for 2 DG Chennai Patrika

Novadoz Pharmaceuticals/MSN Labs gains FDA approval and commences shipping of Pregabalin capsules, the largest generic product launch of the year - PR Newswire

Novadoz Pharmaceuticals/MSN Labs gains FDA approval and commences shipping of Pregabalin capsules, the largest generic product launch of the year PR Newswire

MSN Labs launches Empagliflozin tablets for diabetes management - Telangana Today

MSN Labs launches Empagliflozin tablets for diabetes management Telangana Today

MSN Labs/Novadoz Pharmaceuticals Early Success Continues With FDA Approval Of Generic Abiraterone - PR Newswire

MSN Labs/Novadoz Pharmaceuticals Early Success Continues With FDA Approval Of Generic Abiraterone PR Newswire

Novadoz Has a Fast Start to 2021 with Generic Launches of Albendazole, Droxidopa, Deferasirox Granules, and Pregabalin ER - PR Newswire

Novadoz Has a Fast Start to 2021 with Generic Launches of Albendazole, Droxidopa, Deferasirox Granules, and Pregabalin ER PR Newswire

Breckenridge Pharmaceutical, Inc. Announces Launch of Lacosamide Tablets, USP (generic version of Vimpat®) Manufactured by MSN Laboratories Private Limited - PR Newswire

Breckenridge Pharmaceutical, Inc. Announces Launch of Lacosamide Tablets, USP (generic version of Vimpat®) Manufactured by MSN Laboratories Private Limited PR Newswire

Novadoz Receives Marketing Approval for Generic Versions of Rosuvastatin, Capecitabine, & Moxifloxacin - PR Newswire

Novadoz Receives Marketing Approval for Generic Versions of Rosuvastatin, Capecitabine, & Moxifloxacin PR Newswire

Top Msn Laboratories - Api Division Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant